相关实验视频
Updated: Jul 1, 2026
10:36
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
Published on: August 3, 2018
12.7K
使用参与监测数据库来增强罕见癌症人群的招聘
Michael A O'Rorke1,2, Brian M Gryzlak1, Tao Xu1
1Epidemiology, The University of Iowa, USA.
Journal of clinical and translational science
|March 13, 2026
概括
招募用于罕见癌症研究是困难的. 一个新的监测系统通过跟踪患者接触来提高神经内分泌瘤 (NET) 研究招聘效率和代表性.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 流行病学 流行病学
背景情况:
- 由于符合条件的患者人数有限,为罕见疾病研究招聘存在重大挑战.
- 传统的临床研究系统往往缺乏在招生前跟踪潜在参与者的功能.
- 这项NET-PRO研究旨在解决神经内分泌瘤 (NET) 研究中的这些挑战.
研究的目的:
- 实施和评估参与监测系统,以提高罕见癌症队列研究中的招聘效率和样本代表性.
- 评估灵活多模式招聘策略对研究入学和参与者特征的影响.
- 分析影响招聘困难的因素,并确定不同患者群体的最佳联系方法.
主要方法:
- 这项NET-PRO研究在美国14个中心招募了2538名患有胃肠道胰腺 (GEP) 或肺 NET 的成年人.
- 使用灵活的招聘方法,包括电子邮件,邮件,电话和临床联系人.
- 使用基于REDCap的工具进行联系跟踪和参与者特征管理,并使用统计方法 (SMD,chi-square,ANOVA) 进行分析.
主要成果:
- 在9279名接触患者中,有2538名 (27.4%) 参与注册,其中83.2%的人在线注册.
- 邮件受访者年龄较大,教育程度/收入较低,并与在线注册者相比患上了更多的并发症.
- 招聘困难与年龄较大,教育程度/收入较低相关,超过一半最难招聘的参与者在线报名.
结论:
- 一个参与监测工具促进了灵活的多模式招聘,提高了罕见癌症研究中的样本代表性.
- 追踪招聘联系人允许适应性策略,可能减少观察性研究中的偏见.
- 这种方法可以在罕见疾病研究中改善对难以接触的人群的接触.
相关概念视频
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...